Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-κB Signaling Pathway

Objective. Abnormal signaling pathways play a crucial role in the mechanisms of podocyte injury in diabetic nephropathy. They also affect the recovery of podocytes after islet transplantation (IT). However, the specific signaling abnormalities that affect the therapeutic effect of IT on podocytes re...

Full description

Saved in:
Bibliographic Details
Main Authors: Chongchu Huang, Yi Zhou, Hongjian Huang, Yushu Zheng, Lijun Kong, Hewei Zhang, Yan Zhang, Hongwei Wang, Mei Yang, Xiaona Xu, Bicheng Chen
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2021/9570405
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563197618421760
author Chongchu Huang
Yi Zhou
Hongjian Huang
Yushu Zheng
Lijun Kong
Hewei Zhang
Yan Zhang
Hongwei Wang
Mei Yang
Xiaona Xu
Bicheng Chen
author_facet Chongchu Huang
Yi Zhou
Hongjian Huang
Yushu Zheng
Lijun Kong
Hewei Zhang
Yan Zhang
Hongwei Wang
Mei Yang
Xiaona Xu
Bicheng Chen
author_sort Chongchu Huang
collection DOAJ
description Objective. Abnormal signaling pathways play a crucial role in the mechanisms of podocyte injury in diabetic nephropathy. They also affect the recovery of podocytes after islet transplantation (IT). However, the specific signaling abnormalities that affect the therapeutic effect of IT on podocytes remains unclear. The purpose of this study was to assess whether the RhoA/ROCK/NF-κB signaling pathway is related to podocyte restoration after IT. Methods. A mouse model of diabetic nephropathy was established in vivo using streptozotocin. The mice were then subsequently reared for 4 weeks after islet transplantation to determine the effect of IT. Islet cells, CCG-1423 (RhoA Inhibitor), and fasudil (ROCK inhibitor) were then cocultured with podocytes in vitro to assess their protective effects on podocyte injury induced by high glucose (HG). Protein expression levels of RhoA, ROCK1, synaptopodin, IL-6, and MCP-1 in kidney tissues were then measured using immunohistochemistry and Western blotting techniques. Results. Islet transplantation reduced the expression levels of RhoA/ROCK1 and that of related inflammatory factors such as IL-6 and MCP-1 in the kidney podocytes of diabetic nephropathy. In the same line, islet cells reduced the expression of RhoA, ROCK1, and pp65 in immortalized podocytes under high glucose (35.0 mmol/L glucose) conditions. Conclusions. Islet transplantation can reverse podocyte injury in diabetes nephropathy by inhibiting the RhoA/ROCK1 signaling pathway. Islet cells have a strong protective effect on podocytes treated with high glucose (35.0 mmol/L glucose). Discovery of signaling pathways affecting podocyte recovery is helpful for individualized efficacy evaluation and targeted therapy of islet transplantation patients.
format Article
id doaj-art-052ca8b4e7f24fca8627708c7431571e
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-052ca8b4e7f24fca8627708c7431571e2025-02-03T01:20:44ZengWileyJournal of Diabetes Research2314-67452314-67532021-01-01202110.1155/2021/95704059570405Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-κB Signaling PathwayChongchu Huang0Yi Zhou1Hongjian Huang2Yushu Zheng3Lijun Kong4Hewei Zhang5Yan Zhang6Hongwei Wang7Mei Yang8Xiaona Xu9Bicheng Chen10Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang Province, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang Province, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang Province, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang Province, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang Province, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang Province, ChinaTransplantation Centre, The First Affiliated Hospital of Wenzhou Medical University, 325015 Wenzhou, Zhejiang Province, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang Province, ChinaIntensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, 325015 Wenzhou, Zhejiang Province, ChinaOperating Room, The First Affiliated Hospital of Wenzhou Medical University, 325015 Wenzhou, Zhejiang Province, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang Province, ChinaObjective. Abnormal signaling pathways play a crucial role in the mechanisms of podocyte injury in diabetic nephropathy. They also affect the recovery of podocytes after islet transplantation (IT). However, the specific signaling abnormalities that affect the therapeutic effect of IT on podocytes remains unclear. The purpose of this study was to assess whether the RhoA/ROCK/NF-κB signaling pathway is related to podocyte restoration after IT. Methods. A mouse model of diabetic nephropathy was established in vivo using streptozotocin. The mice were then subsequently reared for 4 weeks after islet transplantation to determine the effect of IT. Islet cells, CCG-1423 (RhoA Inhibitor), and fasudil (ROCK inhibitor) were then cocultured with podocytes in vitro to assess their protective effects on podocyte injury induced by high glucose (HG). Protein expression levels of RhoA, ROCK1, synaptopodin, IL-6, and MCP-1 in kidney tissues were then measured using immunohistochemistry and Western blotting techniques. Results. Islet transplantation reduced the expression levels of RhoA/ROCK1 and that of related inflammatory factors such as IL-6 and MCP-1 in the kidney podocytes of diabetic nephropathy. In the same line, islet cells reduced the expression of RhoA, ROCK1, and pp65 in immortalized podocytes under high glucose (35.0 mmol/L glucose) conditions. Conclusions. Islet transplantation can reverse podocyte injury in diabetes nephropathy by inhibiting the RhoA/ROCK1 signaling pathway. Islet cells have a strong protective effect on podocytes treated with high glucose (35.0 mmol/L glucose). Discovery of signaling pathways affecting podocyte recovery is helpful for individualized efficacy evaluation and targeted therapy of islet transplantation patients.http://dx.doi.org/10.1155/2021/9570405
spellingShingle Chongchu Huang
Yi Zhou
Hongjian Huang
Yushu Zheng
Lijun Kong
Hewei Zhang
Yan Zhang
Hongwei Wang
Mei Yang
Xiaona Xu
Bicheng Chen
Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-κB Signaling Pathway
Journal of Diabetes Research
title Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-κB Signaling Pathway
title_full Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-κB Signaling Pathway
title_fullStr Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-κB Signaling Pathway
title_full_unstemmed Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-κB Signaling Pathway
title_short Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-κB Signaling Pathway
title_sort islet transplantation reverses podocyte injury in diabetic nephropathy or induced by high glucose via inhibiting rhoa rock nf κb signaling pathway
url http://dx.doi.org/10.1155/2021/9570405
work_keys_str_mv AT chongchuhuang islettransplantationreversespodocyteinjuryindiabeticnephropathyorinducedbyhighglucoseviainhibitingrhoarocknfkbsignalingpathway
AT yizhou islettransplantationreversespodocyteinjuryindiabeticnephropathyorinducedbyhighglucoseviainhibitingrhoarocknfkbsignalingpathway
AT hongjianhuang islettransplantationreversespodocyteinjuryindiabeticnephropathyorinducedbyhighglucoseviainhibitingrhoarocknfkbsignalingpathway
AT yushuzheng islettransplantationreversespodocyteinjuryindiabeticnephropathyorinducedbyhighglucoseviainhibitingrhoarocknfkbsignalingpathway
AT lijunkong islettransplantationreversespodocyteinjuryindiabeticnephropathyorinducedbyhighglucoseviainhibitingrhoarocknfkbsignalingpathway
AT heweizhang islettransplantationreversespodocyteinjuryindiabeticnephropathyorinducedbyhighglucoseviainhibitingrhoarocknfkbsignalingpathway
AT yanzhang islettransplantationreversespodocyteinjuryindiabeticnephropathyorinducedbyhighglucoseviainhibitingrhoarocknfkbsignalingpathway
AT hongweiwang islettransplantationreversespodocyteinjuryindiabeticnephropathyorinducedbyhighglucoseviainhibitingrhoarocknfkbsignalingpathway
AT meiyang islettransplantationreversespodocyteinjuryindiabeticnephropathyorinducedbyhighglucoseviainhibitingrhoarocknfkbsignalingpathway
AT xiaonaxu islettransplantationreversespodocyteinjuryindiabeticnephropathyorinducedbyhighglucoseviainhibitingrhoarocknfkbsignalingpathway
AT bichengchen islettransplantationreversespodocyteinjuryindiabeticnephropathyorinducedbyhighglucoseviainhibitingrhoarocknfkbsignalingpathway